Additionally, the study sought to correlate the immunoexpression levels of OCT-4 and NANOG with the demographic and clinicopathological characteristics of OSMF, OSCC+OSMF, and OSCC-OSMF patients. The gene discussed is NANOG; the disease is oral submucous fibrosis.